Lv1
50 积分 2025-03-23 加入
Drug–drug interactions of silymarin on the perspective of pharmacokinetics
8天前
已完结
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
12天前
已完结
An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India
14天前
已完结
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection
14天前
已完结
Fibroblast activation protein in liver fibrosis
14天前
已完结
Sample Size Determination for a Specific Region in a Multiregional Trial
1个月前
已完结
皖公网安备34019202002308
